◀ Back to EGFR

AGO2 — EGFR

Protein-Protein interactions - manually collected from original source literature:

Studies that report less than 10 interactions are marked with *

• IRef Dip Interaction: AGO2 — EGFR (direct interaction, anti tag coimmunoprecipitation) Shen et al., Nature 2013*
• IRef Dip Interaction: AGO2 — EGFR (direct interaction, anti bait coimmunoprecipitation) Shen et al., Nature 2013*
• IRef Dip Interaction: AGO2 — EGFR (direct interaction, protein kinase assay) Shen et al., Nature 2013*
• IRef Dip Interaction: AGO2 — EGFR (direct interaction, -) Shen et al., Nature 2013*
• IRef Dip Interaction: AGO2 — EGFR (direct interaction, pull down) Shen et al., Nature 2013*
• IRef Dip Interaction: Complex of EGFR-EGFR-DICER1-AGO2-AGO2-DICER1 (anti tag coimmunoprecipitation) Shen et al., Nature 2013*
• IRef Dip Interaction: Complex of AGO2-EGFR-DICER1-TARBP2 (anti tag coimmunoprecipitation) Shen et al., Nature 2013*

Text-mined interactions from Literome

Adams et al., Endocrinology 2009 (Breast Neoplasms...) : Argonaute-2 expression is regulated by epidermal growth factor receptor and mitogen activated protein kinase signaling and correlates with a transformed phenotype in breast cancer cells
Hauptmann et al., Dev Cell 2013 : Smibert et al. find that microRNA availability controls Ago levels, and Shen et al. show that epidermal growth factor receptor mediated Ago2 phosphorylation affects Ago loading